Bank of America just raised its EUR/USD forecast
Vyome Holdings, Inc. (NASDAQ:HIND) announced Wednesday that it has amended its Equity Distribution Agreement with Maxim Group LLC to increase the size of its at-the-market public offering of common stock. The company may now issue and sell up to $12 million of its shares, up from the previous limit of $3,420,926. The new offering amount nearly matches the company’s current market capitalization of $12.79 million, according to InvestingPro data. The stock has shown resilience this year with a 4.81% YTD return, trading near $13.88. Shares will be offered under the company’s shelf registration statement on Form S-3, which has been declared effective by the Securities and Exchange Commission. Vyome Holdings has filed a supplement to the prospectus to reflect the increased amount available for sale.
In a separate development, Vyome Holdings reported a change in its independent registered public accounting firm. On Monday, Haskell & White LLP was dismissed as the company’s auditor. The company’s audit committee and board of directors approved the appointment of Kreit & Chiu CPA LLP as the new independent registered public accounting firm for the fiscal year ending December 31, 2025. According to the company’s statement, there were no disagreements with Haskell & White LLP on accounting principles, financial statement disclosure, or auditing procedures during the fiscal year ended December 31, 2024, and the subsequent interim period through Monday. The auditor’s report for the year ended December 31, 2024, included an explanatory paragraph regarding substantial doubt about the company’s ability to continue as a going concern. The company also noted previously reported material weaknesses in internal control over financial reporting as of December 31, 2024.
Vyome Holdings stated that it has provided Haskell & White LLP with a copy of its report and received a letter from the firm regarding the change in auditor, which was filed as an exhibit.
This information is based on a statement made in a press release and the company’s filing with the Securities and Exchange Commission.
In other recent news, Vyome Holdings, Inc. has announced a strategic review of its 70% stake in Livechain Inc., a move that could lead to new opportunities for the company. This development follows Vyome’s recent merger with ReShape Lifesciences, which has been approved for listing on Nasdaq under the ticker symbol "HIND." The merger was accompanied by a 1-for-4 reverse stock split of ReShape’s common stock, effective mid-August 2025. With the merger, Vyome will replace the entire ReShape leadership team, appointing a new Board of Directors with significant ties to the United States and India. Additionally, ReShape Lifesciences has provided a $200,000 loan to Vyome to support merger-related expenses, with the agreement that repayment is not required if the merger completes before the end of September 2025. On another front, ReShape Lifesciences is set to receive a patent for its swallowable balloon device, which is designed for natural excretion after deflation. This patent provides robust protection for the company’s innovative intragastric balloon system. These developments mark significant milestones for both Vyome Holdings and ReShape Lifesciences as they navigate their strategic paths.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.